
Dr John Tsai has been welcomed to the fold as Novartis’ new Head of Global Development and Chief Medical Officer, …

Ipsen is set to expand its executive leadership team with the announcement of two new recruitments: Dr Ivana Magovčević-Liebisch will …

Verona Pharma has revealed that it is to part ways with its Chief Medical Officer at the end of the …

Gilead has announced that Dr Norbert Bischofberger, its Chief Scientific Officer (CSO), Executive Vice President of Research and Development and …

Dr John C Reed, Roche’s Head of Pharma Research and Early Development (pRED), is set to leave the company due …

Stada has revealed its new CEO as Peter Goldschmidt, the current head of North American operations at Novartis’ generics and …

Japanese pharmaceutical firm Astellas has announced that its Board of Directors has approved the selection of current Chief Strategy Officer …

Dr Aidan Murphy has been named by Ipsen’s new Executive Vice President, Technical Operations, succeeding Jonathan Barnsley who retired at …

Biopharmaceutical firm and cellular immunotherapy specialist Juno Therapeutics has named Cindy Elkins as its new Chief Information Officer, where she …

Boehringer Ingelheim is set to part ways with its Chief Financial Officer Simone Menne after 16 months due to fundamental …

Shortly following its announcement of Philippe Mazas as Chief Information Officer, Mundipharma has revealed it has appointed Alberto Martinez as …
Exscientia, an Oxford-based drug design firm which has made headlines this year for its collaboration with GlaxoSmithKline to leverage its …

Gilead had revealed that it has promoted Dr Alessandro Riva, its Senior Vice President, Hematology and Oncology Therapeutic Area Head, …

Allergan has announced that its Executive Vice President and Chief Financial Officer Tessa Hilado intends to step down from her …

French biopharmaceutical group Ipsen has announced that Dr Ian Weatherhead has taken up the position of Vice President, Corporate External …